Therapeutic effects of thymoquinone for the treatment of central nervous system tumors: A review

被引:18
|
作者
Farkhondeh, Tahereh [1 ]
Samarghandian, Saeed [2 ]
Hozeifi, Soroush [3 ]
Azimi-Nezhad, Mohsen [2 ,4 ]
机构
[1] Islamic Azad Univ, Mashhad Branch, Fac Med, Innovat Med Res Ctr, Mashhad, Iran
[2] Neyshabur Univ Med Sci, Dept Basic Med Sci, Neyshabur, Iran
[3] Birjand Univ Med Sci, Fac Med, Birjand, Iran
[4] Mashhad Univ Med Sci, Sch Med, Dept Med Genet, Mashhad, Iran
关键词
Thymoquinone; Tumors; Anti-cancer; CNS; NEUROBLASTOMA NEURO-2A CELLS; NF-KAPPA-B; NIGELLA-SATIVA; OXIDATIVE STRESS; CYCLE ARREST; APOPTOSIS; EXPRESSION; GROWTH; ACTIVATION; LINE;
D O I
10.1016/j.biopha.2017.12.013
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: The aim of this study is to review the effects of thymoquinone (TQ) against central nervous systems (CNS) tumors. Methods: In this study, we extensively reviewed all articles on the terms of N. sativa, TQ, CNS tumors, and different disorders in PubMed, Science Direct, Scopus, and Google Scholar databases between the years 1990 and 2017. Results: The present study found that TQ has many therapeutic effects due to its antioxidant, anti-inflammatory, and anti-proliferative activities. Experimental studies indicated the protective effects of TQ against CNS tumors. The anti-tumor effects of TQ are mainly caused by inducing G2/M cell cycle arrest, apoptotic pathways, inhibiting autophagy, angiogenesis, invasion, and migration and also by enhancing the efficacy of chemotherapeutic drugs. Although, the study observed no significant toxicity of TQ in the experimental models, more clinical studies are needed to confirm the safety and efficacy of TQ for human. Conclusions: The present review found that TQ treatment can be considered as a promising therapeutic strategy for human malignant CNS in future.
引用
收藏
页码:1440 / 1444
页数:5
相关论文
共 50 条
  • [1] A review of gene therapy for the treatment of central nervous system tumors
    Qureshi, NH
    Chiocca, EA
    [J]. CRITICAL REVIEWS IN ONCOGENESIS, 1999, 10 (04): : 261 - 274
  • [2] Late Effects of Treatment of Pediatric Central Nervous System Tumors
    Roddy, Erika
    Mueller, Sabine
    [J]. JOURNAL OF CHILD NEUROLOGY, 2016, 31 (02) : 237 - 254
  • [3] Biomarkers in tumors of the central nervous system - a review
    Scheie, David
    Kufaishi, Huda Haidar Abdallah
    Broholm, Helle
    Lund, Eva Lobner
    de Stricker, Karin
    Melchior, Linea C.
    Grauslund, Morten
    [J]. APMIS, 2019, 127 (05) : 265 - 287
  • [4] THERAPEUTIC CONSIDERATIONS IN TUMORS AFFECTING THE CENTRAL NERVOUS SYSTEM - EPENDYMOMAS
    PHILLIPS, TL
    SHELINE, GE
    BOLDREY, E
    [J]. RADIOLOGY, 1964, 83 (01) : 98 - 105
  • [5] THERAPEUTIC CONSIDERATIONS IN TUMORS AFFECTING THE CENTRAL NERVOUS SYSTEM - OLIGODENDROGLIOMAS
    SHELINE, GE
    BOLDREY, E
    KARLSBERG, P
    PHILLIPS, TL
    [J]. RADIOLOGY, 1964, 82 (01) : 84 - 89
  • [6] A comprehensive review of the therapeutic and pharmacological effects of ginseng and ginsenosides in central nervous system
    Kim, Hee Jin
    Kim, Pitna
    Shin, Chan Young
    [J]. JOURNAL OF GINSENG RESEARCH, 2013, 37 (01) : 8 - 29
  • [7] EVALUATION OF TEMOZOLOMIDE TREATMENT IN CENTRAL NERVOUS SYSTEM TUMORS
    Ates, Dilvin Celik
    Cakir, Fatma Betul
    [J]. PEDIATRIC BLOOD & CANCER, 2023, 70 : S578 - S578
  • [8] Incidence and Treatment of Central Nervous System Tumors in Suriname
    Kuipers, Sander Erik
    Kafiluddin, Erik
    Joe, Rudie Tjong Tjin
    Peerdeman, Saskia
    [J]. WORLD NEUROSURGERY, 2013, 80 (05) : E79 - E83
  • [9] Current treatment options in central nervous system tumors
    Rutkowski, S.
    Mynarek, M.
    Milde, T.
    Dietzsch, S.
    Kortmann, R. D.
    [J]. ONKOLOGE, 2021, 27 (05): : 478 - 484
  • [10] TREATMENT OF CENTRAL NERVOUS-SYSTEM TUMORS WITH METHOTREXATE
    ABELSON, HT
    KUFE, DW
    SKARIN, AT
    MAJOR, P
    ENSMINGER, W
    BEARDSLEY, GP
    CANELLOS, GP
    [J]. CANCER TREATMENT REPORTS, 1981, 65 : 137 - 140